Results 11 to 20 of about 2,520,058 (419)

Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. [PDF]

The Lancet, 2020
BACKGROUND: Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries.
GBD Chronic Kidney Disease Collaboration
core   +8 more sources

Dapagliflozin in Patients with Chronic Kidney Disease.

New England Journal of Medicine, 2020
BACKGROUND Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diabetes, is not known.
H. Heerspink, B. Stefánsson, R. Correa-Rotter, G. Chertow, T. Greene, F. Hou, J. Mann, J. McMurray, M. Lindberg, P. Rossing, C. Sjöström, R. Toto, A. Langkilde, D. Wheeler   +13 more
semanticscholar   +1 more source

Primary extranodal diffuse large B‐cell lymphoma: Molecular features, treatment, and prognosis

Aging and Cancer, Volume 3, Issue 3-4, Page 133-146, September-December 2022., 2022
One‐third of DLBCL arises from extranodal organs and is challenging to manage. Molecular features are critical to elucidate the differences in clinical features, predict the disease prognosis, and improve effective targeted therapeutic strategies. Abstract Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin's lymphoma and ...
Si‐Yuan Chen, Meng‐Meng Ji, Peng‐Peng Xu, Wei‐Li Zhao   +3 more
wiley   +1 more source

Bisphenol A in Chronic Kidney Disease [PDF]

International Journal of Nephrology, 2013
Phenols are uremic toxins of intestinal origin formed by bacteria during protein metabolism. Of these molecules, p-cresol is the most studied and has been associated with renal function impairment and vascular damage. Bisphenol A (BPA) is a molecule with structural similarity with phenols found in plastic food and beverage containers as well as in some
González Parra, Emilio José, Herrero, José Antonio, Elewa, Usama, Bosch, Ricardo J., Ortiz Arduán, Alberto, Egido, Jesús   +5 more
openaire   +5 more sources

Antiphospholipid syndrome: A disease of protean face [PDF]

Journal of Nephropathology, 2013
Background: Antiphospholipid syndrome (APS) is a systemic disorder characterizes by recurrent arterial and venous thrombosis and/or pregnancy miscarriages and positive test for antiphospholipid antibodies.
Mohammadreza Ardalan, Amir Vahedi
doaj   +1 more source

Empagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2022
Background This study, the EMPA-KIDNEY trial, was designed to assess the effects of empagliflozin in a broad range of patients with chronic kidney disease (CKD) at risk of progression. Methods We randomly assigned 6609 participants to empagliflozin (10mg
W. Herrington, N. Staplin, C. Wanner, J. B. Green, S. Hauske, J. Emberson, D. Preiss, P. Judge, Kaitlin J. Mayne, S. Ng, E. Sammons, D. Zhu, M. Hill, W. Stevens, K. Wallendszus, S. Brenner, A. Cheung, Zhi-Hong Liu, Jing Li, L. Hooi, Wen Liu, T. Kadowaki, M. Nangaku, A. Levin, D. Cherney, A. Maggioni, R. Pontremoli, R. Deo, S. Goto, X. Rosselló, K. Tuttle, D. Steubl, M. Petrini, D. Massey, Jens Eilbracht, M. Brueckmann, M. Landray, C. Baigent, R. Haynes   +38 more
semanticscholar   +1 more source

Factors modulating 99mTc‐MAA planar lung dosimetry for 90Y radioembolization

Journal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract Purpose To investigate the accuracy and biases of predicted lung shunt fraction (LSF) and lung dose (LD) calculations via 99mTc‐macro‐aggregated albumin (99mTc‐MAA) planar imaging for treatment planning of 90Y‐microsphere radioembolization.
Benjamin P. Lopez, Armeen Mahvash, James P. Long, Marnix G. E. H. Lam, S. Cheenu Kappadath   +4 more
wiley   +1 more source

A Machine Learning Methodology for Diagnosing Chronic Kidney Disease

IEEE Access, 2023
Chronic kidney disease (CKD) is a global health problem with high morbidity and mortality rate, and it induces other diseases. Since there are no obvious symptoms during the early stages of CKD, patients often fail to notice the disease.
Jiongming Qin, Lin Chen, Yuhua Liu, Chuanjun Liu, Changhao Feng, Bin Chen   +5 more
semanticscholar   +1 more source

Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital

BMC Pediatrics, 2022
Background There are controversy results in the optimal management of children with steroid-dependent and steroid-resistant nephrotic syndrome (SDNS, SRNS).
Behnaz Bazargani, Zahra Noparast, Leila Khedmat, Daryoosh Fahimi, Seyed Taher Esfahani, Mastaneh Moghtaderi, Arash Abbasi, Azadeh Afshin, Sayed Yousef Mojtahedi   +8 more
doaj   +1 more source

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

Diabetes Care, 2022
People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure, atherosclerotic cardiovascular disease, heart failure, and premature mortality. Recent clinical trials support new approaches to treat diabetes and CKD.
I. D. de Boer, K. Khunti, Tami Sadusky, K. Tuttle, Joshua J. Neumiller, Connie M. Rhee, Sylvia E. Rosas, P. Rossing, G. Bakris   +8 more
semanticscholar   +1 more source